Analysts Set Aardvark Therapeutics, Inc. (NASDAQ:AARD) Target Price at $15.33
Aardvark Therapeutics, Inc. (NASDAQ:AARD – Get Free Report) has earned an average rating of “Hold” from the twelve ratings firms that are presently covering the stock, MarketBeat reports. Two investment analysts have rated the stock with a sell recommendation, four have issued a hold recommendation, five have given a buy recommendation and one has issued […]
1 Sep 06:06 · The Markets Daily